Incremental Cost and Length of Stay Associated With Complications of Transcatheter Aortic Valve Replacement

Steven D Culler1, Matthew R Reynolds2, Aaron D Kugelmass3

  • 1Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.

JACC. Advances
|August 27, 2025
PubMed

Insights

Transcatheter aortic valve replacement (TAVR) complications significantly increase hospital costs by over $12,000 per patient. Mitigating these adverse events in TAVR procedures offers substantial cost savings.

Area of Science:

  • Cardiovascular Medicine
  • Health Economics
  • Medical Device Technology

Background:

  • Transcatheter aortic valve replacement (TAVR) is the leading procedure for aortic valve replacement, with nearly 100,000 annual US procedures.
  • The economic impact of TAVR complications on hospital resource utilization remains incompletely understood.

Purpose of the Study:

  • To quantify the additional hospital resource use and associated costs linked to TAVR complications.
  • To analyze the financial burden imposed by adverse events following TAVR procedures.

Main Methods:

  • Utilized the 2020 Medicare Provider Analysis and Review file for 66,893 TAVR beneficiaries.
  • Employed ICD-10-CM codes to identify complications and cost-to-charge ratios for hospital cost calculation.
  • Applied multivariable regression to estimate incremental costs and length of stay (LOS) associated with complications.

Main Results:

  • In 2020, 31.1% of Medicare TAVR patients experienced complications, increasing mean hospitalization costs by $15,377 and LOS by 2.8 days.
  • Risk-adjusted incremental cost of complications was $12,953, with surgical aortic valve replacement, dialysis-requiring renal failure, and in-hospital mortality being the most costly.
  • Complications contributed $320 million in additional costs, representing 8.7% of total Medicare TAVR hospital expenditures.

Conclusions:

  • Approximately one in three Medicare TAVR patients encounter serious complications, significantly elevating hospital resource use.
  • Despite TAVR advancements, substantial cost savings are achievable through focused efforts on complication reduction and mitigation strategies.
Abstract

Related Concept Videos

Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
36
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
52
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
24
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
153
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
42
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
41